{"organizations": [], "uuid": "154c23209cd3a7f72c29f5f7179021c4478f3c5b", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-helix-biopharma-signs-agreement-wi/brief-helix-biopharma-signs-agreement-with-promab-biotechnologies-to-co-developcar-t-for-hematological-malignancies-idUSFWN1R30AU", "country": "US", "domain_rank": 408, "title": "BRIEF-Helix Biopharma Signs Agreement With Promab Biotechnologies To Co-Develop Car-T For Hematological Malignancies", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-21T14:18:00.000+02:00", "replies_count": 0, "uuid": "154c23209cd3a7f72c29f5f7179021c4478f3c5b"}, "author": "", "url": "https://www.reuters.com/article/brief-helix-biopharma-signs-agreement-wi/brief-helix-biopharma-signs-agreement-with-promab-biotechnologies-to-co-developcar-t-for-hematological-malignancies-idUSFWN1R30AU", "ord_in_thread": 0, "title": "BRIEF-Helix Biopharma Signs Agreement With Promab Biotechnologies To Co-Develop Car-T For Hematological Malignancies", "locations": [], "entities": {"persons": [{"name": "promab biotechno", "sentiment": "negative"}], "locations": [], "organizations": [{"name": "co-develop car-t for hematological malignancies reuters staff", "sentiment": "none"}, {"name": "promab biotechnologies", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "helix biopharma corp", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "biopharma corp", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 21, 2018 / 12:21 PM / in 9 minutes BRIEF-Helix Biopharma Signs Agreement With Promab Biotechnologies To Co-Develop Car-T For Hematological Malignancies Reuters Staff 1 Min Read March 21 (Reuters) - Helix Biopharma Corp: * HELIX BIOPHARMA CORP. SIGNS COLLABORATION AGREEMENT WITH PROMAB BIOTECHNOLOGIES TO CO-DEVELOP CAR-T FOR HEMATOLOGICAL MALIGNANCIES Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-03-21T14:18:00.000+02:00", "crawled": "2018-03-21T14:37:01.048+02:00", "highlightTitle": ""}